Gilman Hill Asset Management, LLC / BMY
Gilman Hill Asset Management, LLC’s Bristol-Myers Squibb Co Position
Does Gilman Hill Asset Management, LLC own Bristol-Myers Squibb Co (BMY)? Yes — 231.3K shares worth $13M (+1.82% of its 13F portfolio) as of Q2 2026, up from 230.0K shares the prior filed quarter.
Position Value
$13M
Q2 2026
Shares
231.3K
% of Portfolio
+1.82%
Quarters Held
31
currently held
Position History BMY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2026 | 231.3K | $13M | +1.82% |
| Q1 2026 | 230.0K | $14M | +2.11% |
| Q4 2025 | 237.4K | $13M | +2.02% |
| Q3 2025 | 238.7K | $11M | +1.69% |
| Q2 2025 | 231.8K | $11M | +1.75% |
| Q1 2025 | 221.3K | $13M | +2.34% |
| Q4 2024 | 218.2K | $12M | +2.15% |
| Q3 2024 | 232.1K | $12M | +2.01% |
| Q2 2024 | 233.4K | $10M | +1.75% |
| Q1 2024 | 58.7K | $3M | +0.57% |
| Q4 2023 | 58.1K | $3M | +0.55% |
| Q3 2023 | 58.9K | $3M | +0.67% |
| Q2 2023 | 59.8K | $4M | +0.71% |
| Q1 2023 | 58.7K | $4M | +0.83% |
| Q4 2022 | 57.0K | $4M | +0.84% |
| Q3 2022 | 54.8K | $4M | +0.91% |
| Q2 2022 | 54.4K | $4M | +0.90% |
| Q1 2022 | 58.9K | $4M | +0.98% |
| Q4 2021 | 58.3K | $4M | +0.81% |
| Q3 2021 | 42.9K | $3M | +0.65% |
| Q2 2021 | 40.3K | $3M | +0.69% |
| Q1 2021 | 39.1K | $2M | +0.68% |
| Q4 2020 | 36.1K | $2M | +0.73% |
| Q3 2020 | 35.0K | $2M | +0.82% |
| Q2 2020 | 35.7K | $2M | +0.84% |
| Q1 2020 | 34.8K | $2M | +0.94% |
| Q4 2019 | 34.0K | $2M | +0.71% |
| Q3 2019 | 13.9K | $706,000 | +0.23% |
| Q2 2019 | 14.2K | $645,000 | +0.22% |
| Q1 2019 | 11.8K | $563,000 | +0.20% |
| Q4 2018 | 11.7K | $606,000 | +0.25% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Gilman Hill Asset Management, LLC’s full portfolio or all institutional holders of BMY.